This page contains scientific and technical information intended for registered healthcare professionals. It is not advertising and is not intended for the general public. Infant milk substitute should be used only on the advice of a healthcare professional.
A reference summary of the composition of Nutralac Premium whole-milk infant formula and the peer-reviewed literature relevant to each ingredient and formulation choice. For healthcare professionals.
Nutralac Premium is formulated to the composition for infant formula set out in the FSS (Foods for Infant Nutrition) Regulations, 2020 and Codex STAN 72-1981, and tested to IS 14433. Within those limits, the formulation uses a whole-milk base with retained milk fat, lactose as the sole carbohydrate, a palm-oil-free fat blend, vegetarian algal DHA with fungal ARA, and a GOS/FOS + L. reuteri synbiotic.
Where the milk comes from, who makes the formula, and how each batch is tested and traced.
Milk is sourced directly from local dairy farmers rather than pooled from the open commodity market, keeping the origin of the milk known.
Produced by Nutrimed, a dairy-nutrition manufacturer operating since 2011 and built on a family dairy business of more than three decades, with roughly 28 years of R&D in baby foods and dairy nutrition. Nutrimed manufactures at ISO 22000, HACCP and GMP certified, FSSAI-licensed and NABL-lab-tested facilities in Faridabad and Ballabhgarh (Haryana), and already produces infant milk formula, whole- and skimmed-milk powder and butter. Its founder, a former NDRI food scientist, is credited by the company with earlier formulations including Complan and Farex.
Every batch is tested for microbiological parameters (including Cronobacter and Salmonella) and for heavy metals (lead, arsenic, cadmium, mercury) against the IS 14433 specification before release.
A certificate of analysis is issued for every production batch and is accessible via the QR code on the tin.
Each functional ingredient carries a named origin, so a finished tin can be traced back through its ingredients to their roots.
A technical comparison of common category practice against the Nutralac Premium formulation. “Generic formula” describes typical practice and varies by brand and product; this is not a claim against any named product.
| Parameter | Generic infant formula | Nutralac Premium |
|---|---|---|
| Milk base | Skimmed milk reconstituted with vegetable oils | Whole milk with retained milk fat + butter oil |
| Carbohydrate | Lactose, often with maltodextrin or corn-syrup solids | Lactose only |
| Fat blend | May include palm oil / palm olein | Palm-free: sunflower, coconut, flaxseed |
| DHA source | Fish-derived or algal; ARA varies | Algal DHA (vegetarian) + fungal ARA |
| Gut support | Usually a prebiotic or a probiotic | GOS + FOS prebiotics and L. reuteri DSM 17938 |
| Milk sourcing | Pooled / commodity milk powder | Direct from local farmers |
| Testing & traceability | Statutory minimum | Per-batch microbiology + heavy metals; COA per batch; ingredient-level traceability |
| Added colours / flavours | Permitted; varies by product | None |
Each ingredient with its role in the formula and the relevant evidence base (reference numbers refer to the library below).
Built on whole milk solids with added anhydrous milk fat (butter oil), rather than skimmed milk reconstituted with vegetable oils. This retains naturally occurring milk fat and the fat-soluble vitamins and phospholipids associated with it.
Demineralised whey (90% demineralised) with skimmed milk and whey protein concentrate gives a whey-predominant protein at a level within the standard. Protein quantity in infancy is associated with later weight trajectory.
Lactose is the sole carbohydrate — no maltodextrin, corn-syrup solids or sucrose. Lactose is the physiological, low-glycaemic milk sugar; glucose polymers are permitted but add nothing nutritionally over lactose.
Cold-pressed sunflower oil (linoleic acid), coconut oil and encapsulated flaxseed oil (α-linolenic acid) supply the essential fatty acids the standard requires, without palm oil or palm olein.
Docosahexaenoic acid from algae (Schizochytrium sp.) and arachidonic acid from fungus (Mortierella alpina), formulated in balance, as a permitted optional addition.
Galacto- and fructo-oligosaccharides as non-digestible prebiotic fibres.
Lactobacillus reuteri DSM 17938 as a strain-specific probiotic; together with GOS/FOS it constitutes a synbiotic.
CMP, UMP, AMP, IMP and GMP — the nucleotide profile present in milk.
Added at the level set by the standard; choline is a conditionally essential nutrient present in breast milk.
A conditionally essential amino acid added to the level the standard specifies.
A cofactor for mitochondrial fatty-acid oxidation, present in both breast milk and infant formula.
Myo-inositol, a micronutrient present at high concentration in breast milk.
The full complement of vitamins and minerals, each dosed within the standard's min–max window.
Palm oil, added sugars and maltodextrin are all permitted and safe under Codex and FSSAI. These are optimisation choices toward the composition of milk, not safety claims.
Pancreatic lipase is sn-1,3-specific. In vegetable palm olein most palmitic acid sits at the sn-1 and sn-3 positions, so digestion releases it as free palmitic acid, which binds luminal calcium into insoluble calcium–palmitate soaps lost in stool — carrying both fat and calcium with it. In human milk and in milk fat a larger share of palmitate is esterified at sn-2, where it is absorbed as 2-monopalmitin and does not form soaps; because Nutralac Premium is whole-milk based and palm-free, its fat carries more sn-2 palmitate than a palm-olein blend. A meta-analysis of 9 RCTs found palm-free formulas give significantly softer stools (pooled mean difference −0.355); stool frequency and growth do not differ. Palm oil is permitted and safe under Codex and FSSAI — this is a tolerability and absorption optimisation, not a safety claim.
Lactose, the intrinsic sugar of milk, is the sole carbohydrate. There is no physiological requirement for free sugars in infancy. Infants are born with an innate sweet preference that is biologically maximal in infancy, and sweetening formula amplifies that drive at its most plastic window. Free sugars — with sucrose the paradigmatic cariogenic sugar — are linked to dental caries on moderate-quality evidence, and added sugars in infancy (largely formula-delivered) are associated with rapid early weight gain. ESPGHAN states that in infant formula lactose is the preferred sugar and sucrose, glucose and fructose are not permitted; WHO's free-sugar limits explicitly exempt milk lactose; Codex restricts added sucrose and fructose.
Glucose polymers — maltodextrin, corn-syrup or glucose-syrup solids — are permitted co-carbohydrates (Codex lists them alongside lactose as “preferred”), used mainly for cost, lower sweetness and osmolality control rather than for any infant benefit. Lactose is low-glycaemic (GI ~46); a maltodextrin-based follow-on formula measured a glycaemic index of 63. The one direct lactose-vs-corn-syrup-solids infant trial found no difference in postprandial glucose or insulin, so the case rests on a large WIC cohort (>15,000 children) in which corn-syrup-solids formula carried a modest, dose-dependent higher childhood obesity risk (relative risk ~1.07–1.16), plus associations with rapid infant weight gain and a shifted gut microbiota. Mechanistic work on pathogen adhesion and mucus-barrier breakdown is in-vitro and animal only. Maltodextrin is GRAS and safe; the argument is optimisation toward the milk sugar, not toxicity.
| Parameter | Approach |
|---|---|
| Specification | Tested to IS 14433:2022 (Infant Milk Substitutes) and FSS (Foods for Infant Nutrition) Regulations, 2020 |
| Heavy metals | Batch testing by ICP-MS (lead, arsenic, cadmium, mercury) to IS 14433 specification limits |
| Microbiology | Cronobacter and Salmonella absent; Enterobacteriaceae tested each batch |
| Manufacturer | Nutrimed, Faridabad (Haryana) · FSSAI 10821003000252 |
| Certificate of analysis | Available per batch via the on-pack QR code |
Grouped by ingredient and formulation topic. Standards and expert-group documents are included alongside clinical studies. Checked against published records; PMID/DOI given where available.